Durga Sunkara
Internal Medicine · Pasadena, TXNPI 1194765743
Payments from drug & device makers
Across 166 payments — averaging $17.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$684
- AstraZeneca$450
- AbbVie$392
- Bayer$346
- Amarin Pharma, Inc.$310
- Amgen$127
- plus $666 from 15 others
What the payments were for
- Food & beverage$2,89397%
- Education$833%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 32 | $684 |
| AstraZeneca | 23 | $450 |
| AbbVie(2 entities) | 20 | $392 |
| Bayer | 19 | $346 |
| Amarin Pharma, Inc. | 26 | $310 |
| Amgen | 8 | $127 |
| Astellas Pharma US Inc | 7 | $124 |
| Lilly USA, LLC | 5 | $101 |
| GSK | 4 | $67 |
| Novartis | 4 | $65 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $55 |
| Inspire Medical Systems, Inc. | 2 | $45 |
| Abbott | 2 | $43 |
| Almatica Pharma LLC | 2 | $41 |
| Johnson & Johnson | 2 | $35 |
| Biogen | 1 | $20 |
| Idorsia Pharmaceuticals US Inc | 1 | $16 |
| Exact Sciences | 1 | $16 |
| Boehringer Ingelheim | 1 | $14 |
| Shire North American Group Inc | 1 | $12 |
| Genentech USA, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FARXIGA$125
How this compares
$2,975 in reported general payments places this provider in the 80th percentile of 7,675 internal medicine providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lisinopril | 23 | $144 |
| Levothyroxine Sodium | 16 | $125 |
| Metformin Hcl | 17 | $99 |
| Rosuvastatin Calcium | 18 | $68 |
| Montelukast Sodium | 12 | $62 |
| Amlodipine Besylate | 12 | $24 |
| Carvedilol | 12 | $23 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Pasadena
- Jan BurgerHouston$47.3M
- Nitin JainHouston$33.2M
- Muhammad IrfanTomball$30.6M
- Aung NaingHouston$30.6M
- Robert BassSan Antonio$25.6M
- Preetesh JainHouston$19.5M
- Paolo StratiHouston$19.2M
- Hernan SalazarSan Antonio$18.5M
- Nicholas ShortHouston$17.6M
- Salma SaigerMesquite$16.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.